Crizotinib

solute carrier family 12 member 2 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35619747 Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma. 2022 3
2 33682977 Novel SLC12A2-ROS1 Fusion in Non-Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next-Generation Sequencing Assay. 2021 Jun 2